Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

Overview of attention for article published in Bone Marrow Transplantation, September 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#35 of 5,990)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

Outcomes for patients with relapsed/refractory B-cell lymphoma (BCL) have improved since the introduction of chimeric antigen…

ORLANDO -- Three-fourths of patients with relapsed/refractory large B-cell lymphomas (LBCLs) responded to treatment with a new…

ORLANDO -- Three-fourths of patients with relapsed/refractory large B-cell lymphomas (LBCLs) responded to treatment with a new…

Lisocabtagene maraleucel (liso-cel) demonstrated an objective response rate (ORR) of 73% and a complete response (CR) rate of 53…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.